Literature DB >> 9138233

Treatment of systemic hypertension in cats with amlodipine besylate.

R A Henik1, P S Snyder, L M Volk.   

Abstract

Amlodipine besylate, a calcium channel blocker, was used to treat (mean +/- standard deviation [SD], 127 +/- 68 days) 12 cats with systemic hypertension. Amlodipine was administered orally at a dosage of 0.625 mg per cat (range, 0.08 to 0.23 mg/kg body weight; mean dose +/- SD, 0.17 +/- 0.04 mg/kg body weight) once daily as a single agent. Average indirect systolic blood pressure measurements in the 12 cases decreased significantly from 198 to 155 mmHg during amlodipine treatment. Significant changes in body weight and serum creatinine and potassium concentrations were not detected. Amlodipine appears to be a safe and effective oral treatment for systemic hypertension in cats when used chronically once daily as a single agent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9138233     DOI: 10.5326/15473317-33-3-226

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  6 in total

1.  Randomized placebo-controlled clinical trial of a chewable formulation of amlodipine for the treatment of hypertension in client-owned cats.

Authors:  M Huhtinen; G Derré; H J Renoldi; M Rinkinen; K Adler; J Aspegrén; C Zemirline; J Elliott
Journal:  J Vet Intern Med       Date:  2015-04-09       Impact factor: 3.333

2.  Relationship between indirect blood pressure and various stages of chronic kidney disease in cats.

Authors:  Yasutomo Hori; Yasuhiro Heishima; Yohei Yamashita; Noriko Isayama; Nobuyuki Kanno; Kensuke Nakamura; Masayuki Iguchi; Toshiki Ibaragi; Hideyuki Onodera; Yoshitaka Aramaki; Atsushi Hirakawa; Shigeki Yamano; Michio Katagi; Akihito Kitade; Tamotsu Sawada
Journal:  J Vet Med Sci       Date:  2018-01-03       Impact factor: 1.267

3.  Factors Influencing the Relationship Between the Dose of Amlodipine Required for Blood Pressure Control and Change in Blood Pressure in Hypertensive Cats.

Authors:  E S Bijsmans; M Doig; R E Jepson; H M Syme; J Elliott; L Pelligand
Journal:  J Vet Intern Med       Date:  2016-09       Impact factor: 3.333

4.  Efficacy of long-term oral telmisartan treatment in cats with hypertension: Results of a prospective European clinical trial.

Authors:  Tony M Glaus; Jonathan Elliott; Esther Herberich; Tanja Zimmering; Balazs Albrecht
Journal:  J Vet Intern Med       Date:  2018-12-18       Impact factor: 3.333

5.  ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats.

Authors:  Mark J Acierno; Scott Brown; Amanda E Coleman; Rosanne E Jepson; Mark Papich; Rebecca L Stepien; Harriet M Syme
Journal:  J Vet Intern Med       Date:  2018-10-24       Impact factor: 3.333

Review 6.  The cat with neurological manifestations of systemic disease. Key conditions impacting on the CNS.

Authors:  Marc Kent
Journal:  J Feline Med Surg       Date:  2009-05       Impact factor: 2.015

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.